Contribute to The Michael J. Fox Foundation for Parkinson's Research in memory of Craig

In memory of

John "Craig" Waddell

Scottsdale, AZ

September 1, 1940 - May 13, 2024

Sep 1, 1940 - May 13, 2024

Help keep everyone in the know by sharing this memorial website.

Share

Please consider a contribution to The Michael J. Fox Foundation for Parkinson's Research.

$5,500.00

contributed by 5 people

Show your support: Contribute

Craig was diagnosed with Parkinson's Disease in 2018, and struggled with the toll it took both physically and mentally. Contribute to The Michael J. Fox Foundation for Parkinson's Research

All contributions made to The Michael J. Fox Foundation for Parkinson's Research through Ever Loved will be sent with the designation, “Wherever it is needed most”, at Joanna Shelton and Coralie Waddell's request.

About The Michael J. Fox Foundation for Parkinson's Research

The MJFF is centered around finding and developing the next era of treatments for Parkinson's disease. They are defined by a sense of urgency in finding treatments for Parkinson's disease through research funding, high-risk investing in breakthrough and experimental treatments, connecting the Parkinson's community with each other for a better understanding of the disease.

Frequently asked questions

Answered by a team member at The Michael J. Fox Foundation for Parkinson's Research

What is your mission?

The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.
How are donations used?

The Michael J. Fox Foundation’s research strategy — projects and activities we fund and prioritize for scientific attention and problem-solving — evolves rapidly in concert with advances made in Parkinson’s disease (PD) research. The past two decades have brought substantial growth in understanding PD, in particular the role of genetics and the disease mechanisms that are influenced by genetic changes. This has led to the development and testing of several experimental therapies that have the potential to slow or stop progression — patients’ greatest unmet need.